OTC · NAVBQ
Navidea Biopharmaceuticals, Inc.
$0.00$0.00 (0.0%)
Navidea Biopharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.77% below the high.
Loading market information…
OTC · NMDBF · USD
Stock price
Quote as of Dec 14, 2022, 03:22 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NeonMind Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. Originally incorporated in 2019 as Flourish Mushroom Labs Inc., it rebranded to NeonMind Biosciences Inc. in April 2020. Headquartered in Oakville, Canada, the company operates as a subsidiary of The Yield Growth Corp.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Navidea Biopharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.77% below the high.
$0.00$0.00 (0.0%)
Nanomix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (0.0%)
MobileSmith, Inc.: Healthcare · Medical - Healthcare Information Services.
$0.00$0.00 (0.0%)
EastWest Bioscience Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Gelesis Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00-$0.04 (-99.5%)
E-Qure Corp.: Healthcare · Medical - Devices.
$0.00+$0.00 (+9,900.0%)
Gene Biotherapeutics, Inc.: Healthcare · Biotechnology.
$0.00+$0.00 (0.0%)
GeneThera, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.33% below the high.
